BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This study was to compare the efficacy of 3 doses of vardenafil, 5 mg, 10 mg and 20 mg, with
matching placebo in Chinese male ED patients, treated for a maximum of 12 weeks.